Thermo Fisher Scientific Inc. (NYSE:TMO) has acquired Boulder, Colo.-based picoSpin for an undisclosed amount.
The Waltham, Mass.-based Thermo Fisher will fold picoSpin into its chemical analysis business as part of the Analytical Technologies business unit, according to a prepared release.
Company officials said the purchase of the nuclear magnetic resonance spectrometer maker will expand Thermo Fisher’s portfolio of spectroscopy solutions and its array of analytical tools available to undergraduate and graduate chemistry laboratories.
"Adding picoSpin’s unique product offerings to our existing capabilities in spectroscopy enables us to offer an even broader suite of chemical analysis," VP and general manager of Thermo Fisher’s molecular spectroscopy John Sos said in prepared remarks. "Bringing NMR capabilities to new markets where its practicality has been limited represents significant value for our customers."
The picoSpin-45, which was introduced in 2010, is a shoebox-sized device, 70 times smaller than other devices designed to offer the capabilities of larger spectrometers, Thermo Fisher Scientific said.
The Waltham, Mass.-based medical giant last August opened an offering of senior notes to fund its upcoming $3.5 billion buyout of Swedish blood test maker Phadia. The company last May announced to to acquire Phadia, just days after finally closing a $2 billion deal to purchase Sunnyvale, Calif.-based laboratory equipment maker Dionex Corp. (NSDQ:DNEX).
